Glenview Capital Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Glenview Capital Management LLC
CRD #137640
SEC #801-73695
CIK #0001138995
AUM 6,374.2 M (2026-03-31)
Employees 49 (51% Investors, 0% Brokers)
Fees
Minimum
Phone212-812-4700
Address520 Madison Avenue
New York, NY 10022
Source [IAPD] [EDGAR] [LinkedIn]
Total AUM ($B)
25201510502010201520212027
Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure]
ITEM 5 – FEES AND COMPENSATION

      Prior to investing in a Client, each investor is asked to carefully read and review the particular Client’s
offering and/or governing documents for a complete understanding of the key terms, including, the
compensation received by Glenview and its affiliates and how such compensation is calculated, the expenses
paid by the Client and withdrawal rights. The information contained in this Brochure is only a summary and
is qualified in its entirety by each such Clients’s offering and/or governing documents.

      GCM Investment Partners, L.P., which is an investment vehicle for qualified employees and certain other
persons, does not currently assess management fees or performance-based allocations with respect to its investors. In
addition, the Managed Account will be subject to a separately negotiated fee arrangement. The fee terms applicable
to the Managed Account will differ from those applicable to the Glenview Funds, the Opportunity Funds, the
Healthcare Funds and the Suggestivist Funds, and may include different management fee rates and/or performance-
based compensation structures. As such, any discussion herein relating to the management fees and performance-
based allocations will only apply to the Glenview Funds, Opportunity Funds, the Healthcare Funds and the
Suggestivist Funds.

       Glenview or one of its affiliates typically receives management fees from each Fund based on a percentage of
assets under management and a performance-based allocation based on a percentage of the performance achieved for
such Fund, as described further below.

Management Fees

        Each of the Glenview Funds and Opportunity Funds and certain other affiliated entities pay a (i) 0.5% (equal to
a 2% annual rate) or (ii) 0.125% (equal to a 0.5% annual rate, (in the case of the alternative fee arrangement)1 quarterly
management fee to Glenview based on fee paying assets under management. The Healthcare Funds pay a 0.375%
(equal to 1.5% annual rate) quarterly management fee to Glenview based on fee paying assets under management.
The Suggestivist Funds pay a (i) 0.0625% (equal to a 0.25% annual rate) quarterly management fee to Glenview based
on fee paying assets under management. In each case, management fees are deducted quarterly as of the first day of
each calendar quarter and charged monthly to the account of each management fee paying investor. Management fees
are prorated for any subscriptions made by an investor that are effective other than as of the first day of a calendar
quarter. Similarly, management fees are prorated and reimbursed for any withdrawals made by an investor that are
effective other than as of the last calendar day of a calendar quarter. In the event that an investor in a Fund withdraws
all of its liquid capital and holds only certain illiquid “side pocket” investments which are not redeemable at the option
of the investor (as more fully described in the offering documents for each relevant Fund), Glenview may hold back
a special investment reserve from the distribution of withdrawal proceeds to such an investor for estimated
management fees expected to be incurred or invoice such investor quarterly for its allocable portion of the management
fee.

      From time to time, Glenview, its principals, partners, employees and/or affiliates may receive fees or other
forms of compensation for certain services provided to a portfolio company (e.g., appointment to the board of directors
of a portfolio company) in connection with certain investments made by a Client in such portfolio company
(“Transaction Fees”). Certain Transaction Fees will be used to offset the management fees paid by the Client to
Glenview, as more fully described in the offering documents for each relevant Client. In turn, any such reduction will

       1 Investors in the Glenview Funds and the Opportunity Funds may elect to participate in an “alternative fee arrangement”

whereby (i) Glenview will receive an annual management fee attributable to such an investment equal to 0.5% of such assets (rather
than the 2% annual rate) and (ii) any performance-based allocations attributable to such investment will equal 30% (rather than
20%) of the net appreciation, subject to certain limitations further described herein.

proportionately reduce the management fees borne by an investor that would have otherwise been due from such
investor.

Performance-Based Allocations

      With respect to the Glenview Funds, Opportunity Funds and the Healthcare Funds, certain affiliates of Glenview
receive performance-based allocations equal to (i) 20% or (ii) 30% (in the case of the alternative fee arrangement) 2 of
the net returns of each Fund, which generally includes the net realized and unrealized appreciation allocated to each
investor in the Fund. With respect to the Suggestivist Funds, certain affiliates of Glenview receive performance-based
allocations equal to (i) 10% of the net returns of each Fund, which generally includes the net realized and unrealized
appreciation allocated to each investor in the Fund.

       In each case, performance-based allocations are assessed (i) at the end of the fiscal year of the respective Fund
and (ii) upon full or partial withdrawal of an investor’s capital and re-allocated to certain affiliates of Glenview at such
time, other than the Suggestivist Funds which only assess a performance based allocation upon the return of investor
capital. Performance-based allocations are calculated after deducting certain Fund expenses, including, without
limitation, brokerage commissions, management fees, operational and research costs (as more fully described below).
In calculating the net returns of the Fund, prior losses are carried forward and must be made up before performance-
based allocations are made as further described in the offering documents and governing documents for each Fund.
...
Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure]
ITEM 7 – TYPES OF CLIENTS

      Glenview provides investment advisory services to the Clients as set forth in Item 4. Investors in the Clients
include pension plans, charitable foundations, endowments, fund of funds, sovereign wealth funds, family offices,
investment companies, trusts, high net worth individuals and other entities and institutions.

      Investors in the Clients must meet certain suitability requirements as set forth in each Client’s offering and
governing documents. In addition, the minimum initial investment amount is $1,000,000 for the Glenview Funds and
the Suggestivist Funds, $5,000,000 for the Opportunity Funds and $10,000,000 for the Healthcare Funds. The
minimum investment amount required to maintain an investment is $1,000,000 in respect of the Glenview Funds and
$5,000,000 in respect of the Opportunity Funds. GCM Investment Partners, L.P., which is open to Glenview
principals, partners, employees and certain other persons, requires a $10,000 minimum for initial investments and
account maintenance. The minimum initial investment amounts and minimum maintenance amounts for all Funds
may be waived at the discretion of Glenview or its affiliates.
Sector Form 13F Holdings Value ($B)
CVS Caremark Corp 0.6
Global Payments Inc 0.4
Tenet Healthcare Corp 0.3
Amazon Com Inc 0.2
Teva Pharmaceutical Industries Ltd 0.2
Cigna Corp 0.1
Advanced Micro Devices Inc 0.1
Thermo Fisher Scientific Inc 0.1
Upjohn Inc 0.1
Everett Spinco Inc 0.1
View All
Holdings by Sector ($B)
30241812602011201620212027
Type Form D Funds Date Sold AUM
HF GCM Suggestivist I Master Fund LP [2024-08-22] 40.6 M
Filed 2024-06-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000,000 · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
HF Glenview Healthcare Master Fund LP [2021-08-24] 2.8 M 105.5 M
Filed 2026-01-30 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Glenview Healthcare Partners LP 2020-08-21 14.9 M
HF GCM Equity Master Fund LP [2015-11-20] 188.2 M 630.3 M
Filed 2020-11-20 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF GCM Investment Partners LP [2012-02-14] 96.3 M 52.0 M
Filed 2026-01-30 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF GCM Little Arbor Institutional Partners LP 2012-02-14 1.6 M
HF GCM Little Arbor Master Fund Ltd 2012-02-14 6.2 M
HF GCM Little Arbor Partners LP 2012-02-14 0.2 M
HF GCM Opportunity Fund LP [2012-02-14] 222.0 M 256.7 M
Filed 2012-03-14 (D/A) · Exemption 506, 3(c), 3(c)(1) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Glenview Capital Master Fund Ltd 2012-02-14 2,527.4 M
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 5 6.4
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 5 6.4
By Discretionary
Discretionary 5 6.4
Non-Discretionary 0 0.0
Total 5 6.4
By Non-United States Persons
Non-United States Persons 6.3
United States Persons 0.1
Total 5 6.4
Form D Directors Role # Filings # Firms 2011 - 2026
Grant Jackson Director 175 39
Russell Burt Director 113 29
J Hunter Director 61 13
Michael Burke Director, Executive Officer 52 4
Tilly Directors Limited Director 10 4
Jeffrey Patterson Executive Officer 28 3
Richard Barrera Executive Officer 11 3
Mark Horowitz Executive Officer 20 2
John Rodin Executive Officer 17 2
Glenview Capital Management LLC Executive Officer 16 2
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001138995]
3 [0001138995]
4 [0001138995]
SC 13D [0001138995]
SC 13G [0001138995]
Form 13D/13G Filer Form 13D/13G Subject Filed
Glenview Capital Management LLC Genius Sports Ltd [2026-05-21]
Glenview Capital Management LLC DXC Technology Co [2026-03-27]
Glenview Capital Management LLC Myriad Genetics Inc [2026-01-13]
Glenview Capital Management LLC Zoominfo Technologies Inc [2025-07-11]
Glenview Capital Management LLC Alight Inc / Delaware [2024-10-18]
Glenview Capital Management LLC Alight Inc / Delaware [2024-01-16]
Glenview Capital Management LLC DXC Technology Co [2023-11-13]
Glenview Capital Management LLC Myriad Genetics Inc [2023-03-01]
Glenview Capital Management LLC Meritor Inc [2022-02-22]
Glenview Capital Management LLC Newhold Investment Corp [2021-06-04]
Glenview Capital Management LLC Tenet Healthcare Corp [2021-04-22]
Glenview Capital Management LLC Longview Acquisition Corp II [2021-04-02]
Glenview Capital Management LLC Highcape Capital Acquisition Corp [2021-03-15]
Glenview Capital Management LLC Fortress Value Acquisition Corp II [2021-03-08]
Glenview Capital Management LLC Velocity Acquisition Corp [2021-03-05]
Glenview Capital Management LLC Bausch Health Companies Inc [2020-07-27]
Glenview Capital Management LLC Bausch Health Companies Inc [2020-04-09]
Glenview Capital Management LLC Meritor Inc [2019-11-13]
Glenview Capital Management LLC Brookdale Senior Living Inc [2019-10-31]
Glenview Capital Management LLC Meritor Inc [2019-10-18]
Glenview Capital Management LLC Brookdale Senior Living Inc [2019-09-27]
Glenview Capital Management LLC ENDO International PLC [2019-05-20]
Glenview Capital Management LLC Livent Corp [2019-03-14]
Glenview Capital Management LLC Newell Brands Inc [2018-03-23]
Glenview Capital Management LLC First Data Corp [2017-12-26]
Glenview Capital Management LLC ENDO International PLC [2017-11-13]
Glenview Capital Management LLC Hertz Global Holdings Inc [2016-12-27]
Glenview Capital Management LLC Computer Sciences Corp [2016-09-02]
Glenview Capital Management LLC Tenet Healthcare Corp [2016-01-19]
Glenview Capital Management LLC Humana Inc [2015-11-27]
Glenview Capital Management LLC Laboratory Corp of America Holdings [2015-11-19]
Glenview Capital Management LLC Manitowoc Co Inc [2015-11-18]
Glenview Capital Management LLC FMC Corp [2015-10-22]
Glenview Capital Management LLC Hertz Global Holdings Inc [2015-09-04]
Glenview Capital Management LLC Healthsouth Corp [2015-07-31]
Glenview Capital Management LLC ManpowerGroup Inc [2015-06-25]
Glenview Capital Management LLC Manitowoc Co Inc [2015-06-01]
Glenview Capital Management LLC Brookdale Senior Living Inc [2015-03-23]
Glenview Capital Management LLC Manitowoc Co Inc [2015-03-23]
Glenview Capital Management LLC Lithia Motors Inc [2014-12-22]
Glenview Capital Management LLC AVIS Budget Group Inc [2014-12-22]
Glenview Capital Management LLC PVH Corp /DE/ [2014-12-22]
Glenview Capital Management LLC PHH Corp [2014-12-01]
Glenview Capital Management LLC Teradyne Inc [2014-11-17]
Glenview Capital Management LLC Cadence Design Systems Inc [2014-11-10]
Glenview Capital Management LLC Fossil Group Inc [2014-09-15]
Glenview Capital Management LLC Group 1 Automotive Inc [2014-08-11]
Glenview Capital Management LLC Carters Inc [2014-07-15]
Glenview Capital Management LLC VCA Antech Inc [2014-05-29]
Glenview Capital Management LLC Evertec Inc [2013-12-19]
Glenview Capital Management LLC J C Penney Co Inc [2013-09-03]
Glenview Capital Management LLC KV Pharmaceutical Co /DE/ [2013-08-05]
Glenview Capital Management LLC Health Management Associates Inc [2013-05-06]
Glenview Capital Management LLC URS Corp /New/ [2013-03-08]
Glenview Capital Management LLC Lifepoint Hospitals Inc [2013-02-25]
Glenview Capital Management LLC Community Health Systems Inc [2012-11-23]
Glenview Capital Management LLC ROVI Corp [2012-07-30]
Glenview Capital Management LLC URS Corp /New/ [2012-04-27]
Glenview Capital Management LLC Health Management Associates Inc [2012-04-23]
Glenview Capital Management LLC Mueller Water Products Inc [2012-04-12]
Glenview Capital Management LLC Tenet Healthcare Corp [2012-03-23]
Firm Profile (Form ADV)
Discretionary AUM$13.9B
Clients5 (80 non-US)
ServesInstitutional
Fund TypesHedge Fund
LEI54930039JTXQWUT3QP90
Form 3/4/5 Subject 2011 - 2026
Glenview Capital Management LLC
Robbins Larry
Tenet Healthcare Corp
Meritor Inc
Brookdale Senior Living Inc
Flex Ltd
Community Health Systems Inc
VCA Inc
Health Management Associates Inc
K-V Pharmaceutical Co
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2021-04-22 Sell 26,197 $54.95 1,439,525
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2021-04-22 Sell 82,873 $57.28 4,746,965
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2021-04-22 Sell 26,197 $56.25 1,473,581
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2021-04-22 Sell 2,572,941 $55.01 141,537,484
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2021-04-22 Sell 249,702 $56.46 14,098,175
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2021-04-21 Sell 58,000 $55.57 3,223,060
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2021-04-21 Sell 64,090 $55.10 3,531,359
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2021-03-22 Sell 2,500,000 $53.30 133,250,000
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2021-02-02 Sell 3,100 $51.80 160,580
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2021-02-02 Sell 2,000,000 $48.50 97,000,000
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2021-02-02 Sell 30,390 $50.85 1,545,332
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2020-12-18 Sell 77,099 $41.22 3,178,021
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2020-12-17 Sell 185,000 $41.19 7,620,150
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2020-12-16 Sell 28,081 $40.75 1,144,301
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2020-12-16 Sell 12,363 $41.96 518,751
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2020-12-15 Sell 187,017 $42.31 7,912,689
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2020-12-15 Sell 152,267 $41.27 6,284,059
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2020-12-14 Sell 29,787 $42.09 1,253,735
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2020-12-14 Sell 201,903 $40.22 8,120,539
Tenet Healthcare Corp THC
Common Stock, $0.05 par value
2020-12-14 Sell 129,026 $41.06 5,297,808
showing 20 of 88 most recent transactions
Comparable Firms State AUM
Southpoint Capital Advisors LP
NY 6,626.2 M
K2/D&S Management Co LLC
CT 6,534.8 M
Foxhaven Asset Management LP
VA 6,504.3 M
Spider Management Company LLC
VA 6,413.3 M
Maple Rock Capital Partners Inc
6,341.0 M
Landmark Management LLC
NY 6,294.7 M
Cross Ocean Partners Management LP
CT 6,285.1 M
Dorsal Capital Management LP
CA 6,190.9 M
RiverNorth Capital Management LLC
FL 6,167.8 M
BVF Partners LP
CA 6,107.9 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com